Medical Devices industry stocks
142 companies in the Medical Devices industry. 78 have a published intrinsic value and 14 trade at least 20% below it.
The median company in Medical Devices with a published value trades 46% above our estimate of intrinsic value.
Values as of the 22 Sept 2026 close.
Most undervalued stocks in Medical Devices
- Orthofix Medical Inc (OFIX): undervalued, +79% margin of safety
- AdaptHealth Corp (AHCO): undervalued, +72% margin of safety
- Viemed Healthcare Inc (VMD): undervalued, +49% margin of safety
- Inmode Ltd (INMD): undervalued, +42% margin of safety
- Zimmer Biomet Holdings Inc (ZBH): undervalued, +39% margin of safety
- Owlet Inc (OWLT): undervalued, +36% margin of safety
- Globus Medical Inc (GMED): undervalued, +36% margin of safety
- Boston Scientific Corp (BSX): undervalued, +30% margin of safety
- GE HealthCare Technologies Inc (GEHC): undervalued, +29% margin of safety
- Bioventus Inc (BVS): undervalued, +24% margin of safety
Liquid names only: at least $1M traded a day and $50M of market value.
Largest companies in Medical Devices
- Abbott Laboratories (ABT): overvalued, -48% margin of safety
- Medtronic Plc (MDT): overvalued, -25% margin of safety
- Stryker Corp (SYK): overvalued, -35% margin of safety
- Boston Scientific Corp (BSX): undervalued, +30% margin of safety
- Edwards Lifesciences Corp (EW): overvalued, -110% margin of safety
- Dexcom Inc (DXCM): overvalued, -61% margin of safety
- GE HealthCare Technologies Inc (GEHC): undervalued, +29% margin of safety
- Koninklijke Philips NV ADR (PHG): overvalued, -37% margin of safety
- Steris Plc (STE): slightly overvalued, -8% margin of safety
- Zimmer Biomet Holdings Inc (ZBH): undervalued, +39% margin of safety
- Penumbra Inc (PEN): overvalued, -186% margin of safety
- Smith & Nephew plc ADR (SNN): slightly undervalued, +16% margin of safety
- 10x Genomics Inc (TXG): not valued
- Bio-Rad Laboratories Inc (BIO): overvalued, -254% margin of safety
- Globus Medical Inc (GMED): undervalued, +36% margin of safety
- Insulet Corp (PODD): slightly undervalued, +9% margin of safety
- Glaukos Corp (GKOS): overvalued, -813% margin of safety
- Bruker Corp (BRKR): overvalued, -239% margin of safety
- Haemonetics Corp (HAE): overvalued, -71% margin of safety
- LivaNova PLC (LIVN): overvalued, -23% margin of safety
- Integer Holdings Corp (ITGR): overvalued, -88% margin of safety
- iRhythm Holdings Inc (IRTC): overvalued, -1163% margin of safety
- Transmedics Group Inc (TMDX): overvalued, -36% margin of safety
- Neogen Corp (NEOG): not valued
- Butterfly Network Inc (BFLY): overvalued, -1286% margin of safety
- Axogen Inc (AXGN): overvalued, -279% margin of safety
- Alamar Biosciences Inc (ALMR): no published value
- UFP Technologies Inc (UFPT): slightly overvalued, -8% margin of safety
- Establishment Labs Holdings Inc (ESTA): overvalued, -321% margin of safety
- Inspire Medical Systems Inc (INSP): slightly undervalued, +16% margin of safety
- NovoCure Ltd (NVCR): overvalued, -77% margin of safety
- Alphatec Holdings Inc (ATEC): overvalued, -72% margin of safety
- Conmed Corp (CNMD): overvalued, -84% margin of safety
- Integra Lifesciences Holdings Corp (IART): overvalued, -90% margin of safety
- Beta Bionics Inc (BBNX): not valued
- Tandem Diabetes Care Inc (TNDM): fairly valued, +0% margin of safety
- Artivion Inc (AORT): overvalued, -72% margin of safety
- Bioventus Inc (BVS): undervalued, +24% margin of safety
- Iradimed Corp (IRMD): overvalued, -100% margin of safety
- Enovis Corp (ENOV): not valued
- Procept BioRobotics Corp (PRCT): overvalued, -34% margin of safety
- Lumexa Imaging Holdings Inc (LMRI): no published value
- Ceribell Inc (CBLL): not valued
- SI-BONE Inc (SIBN): overvalued, -136% margin of safety
- Inmode Ltd (INMD): undervalued, +42% margin of safety
- Anteris Technologies Global Corp (AVR): not valued
- AdaptHealth Corp (AHCO): undervalued, +72% margin of safety
- Varex Imaging Corp (VREX): overvalued, -278% margin of safety
- QuidelOrtho Corp (QDEL): not valued
- Cytek BioSciences Inc (CTKB): overvalued, -45% margin of safety
- SS Innovations International Inc (SSII): not valued
- OrthoPediatrics corp (KIDS): overvalued, -79% margin of safety
- Delcath Systems Inc (DCTH): overvalued, -4621% margin of safety
- Brainsway Ltd ADR (BWAY): overvalued, -157% margin of safety
- Cerus Corp (CERS): slightly overvalued, -7% margin of safety
- Senseonics Holdings Inc (SENS): overvalued, -962% margin of safety
- Tactile Systems Technology Inc (TCMD): slightly undervalued, +15% margin of safety
- NeuroPace Inc (NPCE): overvalued, -305% margin of safety
- ClearPoint Neuro Inc (CLPT): overvalued, -1223% margin of safety
- Sight Sciences Inc (SGHT): overvalued, -202% margin of safety
- 908 Devices Inc (MASS): overvalued, -225% margin of safety
- Pacific Biosciences of California Inc (PACB): not valued
- Shoulder Innovations Inc (SI): not valued
- Orthofix Medical Inc (OFIX): undervalued, +79% margin of safety
- Viemed Healthcare Inc (VMD): undervalued, +49% margin of safety
- Perspective Therapeutics Inc (CATX): overvalued, -282% margin of safety
- CapsoVision Inc (CV): not valued
- Mobia Medical Inc (MOBI): no published value
- TriSalus Life Sciences Inc (TLSI): not valued
- Treace Medical Concepts Inc (TMCI): not valued
- Standard BioTools Inc (LAB): slightly undervalued, +5% margin of safety
- AVITA Medical Inc (RCEL): overvalued, -230% margin of safety
- InfuSystem Holdings Inc (INFU): overvalued, -77% margin of safety
- Electromed Inc (ELMD): undervalued, +23% margin of safety
- Neuronetics Inc (STIM): slightly overvalued, -17% margin of safety
- Profound Medical Corp (PROF): overvalued, -368% margin of safety
- RxSight Inc (RXST): not valued
- Lucid Diagnostics Inc (LUCD): not valued
- Quantum-Si Incorporated (QSI): not valued
- Owlet Inc (OWLT): undervalued, +36% margin of safety
- Quanterix Corp (QTRX): slightly undervalued, +12% margin of safety
- Nyxoah SA (NYXH): overvalued, -113% margin of safety
- Inogen Inc (INGN): no reliable verdict
- MaxCyte Inc (MXCT): not valued
- Apyx Medical Corp (APYX): fairly valued, +2% margin of safety
- ElectroCore Inc (ECOR): overvalued, -82% margin of safety
- Microbot Medical Inc (MBOT): not valued
- LENSAR Inc (LNSR): slightly overvalued, -10% margin of safety
- Pulmonx Corp (LUNG): not valued
- Hyperfine Inc (HYPR): overvalued, -82% margin of safety
- Sera Prognostics Inc (SERA): not valued
- CVRx Inc (CVRX): overvalued, -23% margin of safety
- Myomo Inc (MYO): fairly valued, -1% margin of safety
- TELA Bio Inc (TELA): undervalued, +39% margin of safety
- Outset Medical Inc (OM): not valued
- Nano X Imaging Ltd (NNOX): not valued
- Rapid Micro Biosystems Inc (RPID): overvalued, -135% margin of safety
- Envoy Medical Inc (COCH): not valued
- Spectral AI Inc (MDAI): not valued
- Sensus Healthcare Inc (SRTS): not valued
Other Healthcare industries
All industries